Evercore PCA vs. Ducera RX
Debating between these two groups and having trouble deciding. Not sure if I prefer Secondaries, RX, M&A, etc. Not sure I would want to exit into but not necessarily thinking about PE exit. I like how Ducera allows to explore between RX, M&A and new VC platform, and how small firm is opportunities to work with senior level people. I like how Evercore PCA has crazy deal flow and also lots of opportunities at junior level, especially as no. 1 market leader in PCA. Enjoyed people I spoke to at both firms (so this makes hard to decide). Would appreciate any insights on considerations/advice which to choose or just maybe things to consider.
The no.1 player in PCA on one side VS the no. 6 - 8 player in RX on the other. Do you want to do RX or PCA? If you don't have a particularly preference for RX seems easy decision to me.
I might be wrong, but doesn't PCA advise institutions on selling their stakes in Funds or advise on continuation vehicles?? I know you said you are not sure what you want to do, but given that I would say take what gives you the most options. I don't believe a PCA skillset is going to traslate to many buyside roles, so it seems like you would be limiting yourself pretty substaintialy, and unless you were sure that you want to do secondaries, that just doesn't seem like a great idea.
That’s not what PCA Is. It’s raising capital.
You’re thinking of secondaries advisory
He’s correct on PCA. Private funds (different group at EVR) deals with capital raising. PCA does LP-led (selling LP interests in funds) and GP-led (single / multi asset continuation funds) advisory work.
Rerum qui sunt eligendi illum praesentium. Ex nobis cumque expedita aliquam eum. Molestias repudiandae ipsum quo quia unde maxime et. Illo pariatur labore perspiciatis rem iure dolor.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...